Clinical Trials Logo

Newly Diagnosed Breast Cancer clinical trials

View clinical trials related to Newly Diagnosed Breast Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT03510988 Terminated - Clinical trials for Newly Diagnosed Breast Cancer

Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer

Start date: March 15, 2018
Phase: N/A
Study type: Interventional

This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of disease prior to surgical and oncologic management. The study will investigate any incremental added benefit to breast MRI specificity by the addition of concurrent hybrid breast PET.

NCT ID: NCT01722851 Completed - Breast Cancer Clinical Trials

Circulating miRNAs.

Start date: May 2011
Phase:
Study type: Observational

To identify a panel of circulating miRNA markers which could help identify those breast cancer patients who are most likely to respond well to neoadjuvant and adjuvant chemotherapy, and indeed serve as an overall prognostic factor and stratify patients into risk categories which would further guide their management. Similarly, the investigators aim to identify a panel of circulating miRNA markers which could monitor patient's response to chemotherapy and hormonal therapies. Ideally a suitable panel of markers would show significant changes in expression level in good-responders whilst little or no change would be observed in miRNA expression in non-responders.

NCT ID: NCT01176838 Terminated - Clinical trials for Newly Diagnosed Breast Cancer

A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients

Start date: November 2008
Phase: N/A
Study type: Observational

The purpose of this study is to provide the physicians with quality long term follow up data on subjects from the Breast Cancer Clinic and the Plastic Surgery Clinic who have been newly diagnosed with breast cancer and will receive treatment for the cancer at this facility. Over the last two decades many studies have been done concerning the quality of life after a mastectomy and/or reconstruction process. The majority of these studies only run for one year post reconstruction, some however, do include a two year follow up. The investigators are proposing a 5 year long term follow up study on subjects who will be diagnosed and treated here at the Breast Cancer Clinic and the Plastic Surgery Clinic. The investigators first questionnaire will be given prior to any treatment for breast cancer, giving us a baseline for the subject's current quality of life. At each successive year, the subject will be given another questionnaire with regards to their progression through the reconstructive process. At the end of 5 years, the subject will complete a final questionnaire. These questionnaires will deal with many areas of daily life functions; activities of daily living, anxiety, depression, social interactions, personal and sexual relationships.

NCT ID: NCT01064427 Recruiting - Clinical trials for Newly Diagnosed Breast Cancer

Factors Correlated With Fatigue in Breast Cancer

FATSEIN
Start date: July 2008
Phase: N/A
Study type: Observational

The aim of this study is to identify the determinants of cancer-related fatigue, and the long-term effect of the different adjuvants treatments will be explored. A prospective longitudinal study in women diagnosed for the first time with stage I-III breast cancer and who have undergone surgery, has been designed to meet the study aims.